Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.29 trillion and total revenue of $114.73 billion.
Market Cap
1.29T
Revenue
114.73B
Profits
-40.56B
PE Ratio
n/a
Profit Margin
-35.35%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 125.73B | 2.49% | 992,492 | 12.59B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 78.32B | 1.59% | 716,779 | 15.53B |
| 3 | ARGX | argenx SE | 55.18B | -1.17% | 249,977 | 5.32B |
| 4 | RVMD | Revolution Medicines, Inc. | 43.61B | 3.71% | 1,665,031 | - |
| 5 | ONC | BeOne Medicines AG | 39.60B | 5.60% | 638,193 | 6.13B |
| 6 | RPRX | Royalty Pharma plc | 32.64B | -0.86% | 3,805,447 | 2.54B |
| 7 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.33B | 1.43% | 1,702,556 | 4.80B |
| 8 | INSM | Insmed Incorporated | 28.63B | -1.09% | 4,904,625 | 1.14B |
| 9 | ROIV | Roivant Sciences Ltd. | 26.25B | 3.47% | 6,670,885 | 7.53M |
| 10 | INCY | Incyte Corporation | 24.44B | 1.84% | 1,540,363 | 5.82B |
| 11 | MRNA | Moderna, Inc. | 23.62B | 9.86% | 6,820,582 | 2.23B |
| 12 | BNTX | BioNTech SE | 23.53B | 2.72% | 1,427,587 | 3.03B |
| 13 | GMAB | Genmab A/S | 18.45B | 4.66% | 3,507,124 | 4.13B |
| 14 | ASND | Ascendis Pharma A/S | 16.84B | 2.23% | 325,549 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 16.65B | -0.04% | 970,710 | 4.60B |
| 16 | BBIO | BridgeBio Pharma, Inc. | 16.51B | 2.03% | 2,148,200 | 579.96M |
| 17 | EXEL | Exelixis, Inc. | 13.40B | 3.58% | 3,549,965 | 2.44B |
| 18 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.38B | 2.12% | 948,140 | 669.50M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 12.35B | 3.82% | 4,364,508 | 3.41B |
| 20 | CORT | Corcept Therapeutics Incorporated | 11.97B | 2.61% | 769,035 | 830.81M |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.78B | -0.06% | 347,529 | 1.28B |
| 22 | HALO | Halozyme Therapeutics, Inc. | 11.70B | 20.24% | 7,833,817 | 1.66B |
| 23 | ABVX | ABIVAX Société Anonyme | 11.37B | 0.72% | 1,100,265 | 5.67M |
| 24 | TECH | Bio-Techne Corporation | 11.26B | 0.54% | 5,577,377 | 1.21B |
| 25 | SMMT | Summit Therapeutics Inc. | 11.14B | 3.10% | 2,180,961 | - |
| 26 | AXSM | Axsome Therapeutics, Inc. | 10.95B | 1.24% | 1,023,411 | 708.24M |
| 27 | CYTK | Cytokinetics, Incorporated | 10.67B | -5.67% | 3,604,382 | 67.67M |
| 28 | APGE | Apogee Therapeutics, Inc. | 10.12B | 0.26% | 1,490,074 | - |
| 29 | PRAX | Praxis Precision Medicines, Inc. | 10.06B | -2.54% | 454,827 | 7.46M |
| 30 | KRYS | Krystal Biotech, Inc. | 9.66B | 1.17% | 160,022 | 440.48M |
| 31 | IONS | Ionis Pharmaceuticals, Inc. | 9.40B | 3.80% | 2,009,200 | 874.09M |
| 32 | PTGX | Protagonist Therapeutics, Inc. | 9.38B | -0.21% | 321,055 | 281.99M |
| 33 | SYRE | Spyre Therapeutics, Inc. | 9.25B | 1.44% | 526,560 | - |
| 34 | KYMR | Kymera Therapeutics, Inc. | 8.94B | 1.04% | 463,568 | 105.00M |
| 35 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.92B | 0.19% | 1,941,775 | 42.16M |
| 36 | PCVX | Vaxcyte, Inc. | 8.39B | -1.39% | 1,296,245 | - |
| 37 | IMVT | Immunovant, Inc. | 8.25B | 0.53% | 906,297 | - |
| 38 | IBRX | ImmunityBio, Inc. | 8.10B | 4.37% | 9,390,077 | 165.79M |
| 39 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.96B | 3.15% | 672,760 | 239.92M |
| 40 | COGT | Cogent Biosciences, Inc. | 7.24B | 1.41% | 1,855,577 | - |
| 41 | TGTX | TG Therapeutics, Inc. | 7.06B | 0.42% | 1,768,420 | 799.54M |
| 42 | CGON | CG Oncology, Inc. | 6.62B | 0.33% | 611,586 | 6.23M |
| 43 | MIRM | Mirum Pharmaceuticals, Inc. | 6.54B | 6.94% | 838,968 | 618.07M |
| 44 | CAI | Caris Life Sciences, Inc. | 6.43B | 13.70% | 9,399,425 | 989.61M |
| 45 | BLTE | Belite Bio, Inc | 6.41B | 1.48% | 126,411 | - |
| 46 | ERAS | Erasca, Inc. | 6.39B | 0.77% | 2,096,111 | - |
| 47 | SRRK | Scholar Rock Holding Corporation | 6.34B | 0.53% | 958,335 | - |
| 48 | DFTX | Definium Therapeutics, Inc. | 6.12B | - | 2,546,997 | - |
| 49 | XENE | Xenon Pharmaceuticals Inc. | 6.12B | -1.84% | 720,233 | 7.50M |
| 50 | PTCT | PTC Therapeutics, Inc. | 6.12B | 3.47% | 951,261 | 1.01B |
| 51 | DNTH | Dianthus Therapeutics, Inc. | 6.09B | -0.91% | 570,168 | 1.90M |
| 52 | ORKA | Oruka Therapeutics, Inc. | 5.96B | 0.41% | 308,654 | - |
| 53 | LGND | Ligand Pharmaceuticals Incorporated | 5.81B | -2.33% | 291,188 | 290.54M |
| 54 | TVTX | Travere Therapeutics, Inc. | 5.78B | -1.81% | 1,226,432 | 591.33M |
| 55 | CRSP | CRISPR Therapeutics AG | 5.17B | 3.64% | 1,284,025 | 13.39M |
| 56 | ACAD | ACADIA Pharmaceuticals Inc. | 5.03B | 2.67% | 1,781,855 | 1.14B |
| 57 | DYN | Dyne Therapeutics, Inc. | 4.90B | 1.43% | 1,990,980 | - |
| 58 | MANE | Veradermics, Incorporated | 4.78B | 5.28% | 542,265 | - |
| 59 | EWTX | Edgewise Therapeutics, Inc. | 4.68B | -2.03% | 1,478,270 | - |
| 60 | CELC | Celcuity Inc. | 4.52B | -0.50% | 542,809 | - |
| 61 | PBLS | Parabilis Medicines, Inc. | 4.45B | -1.69% | 279,759 | - |
| 62 | RLAY | Relay Therapeutics, Inc. | 4.31B | 0.10% | 2,314,901 | 10.35M |
| 63 | ELVN | Enliven Therapeutics, Inc. | 4.22B | 0.32% | 696,061 | - |
| 64 | LEGN | Legend Biotech Corporation | 4.01B | 7.62% | 2,610,748 | 1.14B |
| 65 | VKTX | Viking Therapeutics, Inc. | 4.00B | 2.88% | 1,402,492 | - |
| 66 | DNLI | Denali Therapeutics Inc. | 3.94B | 0.40% | 1,750,014 | 3.60M |
| 67 | TNGX | Tango Therapeutics, Inc. | 3.92B | -6.66% | 3,231,205 | 56.99M |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.89B | 8.27% | 212,702 | 803.79M |
| 69 | GPCR | Structure Therapeutics Inc. | 3.78B | 0.99% | 329,338 | - |
| 70 | RCUS | Arcus Biosciences, Inc. | 3.64B | 1.02% | 1,061,511 | 117.00M |
| 71 | IDYA | IDEAYA Biosciences, Inc. | 3.57B | 2.15% | 602,270 | 234.13M |
| 72 | ALMS | Alumis Inc. | 3.52B | -0.72% | 782,673 | 8.40M |
| 73 | CLDX | Celldex Therapeutics, Inc. | 3.27B | 0.46% | 808,911 | 158.00K |
| 74 | NAMS | NewAmsterdam Pharma Company N.V. | 3.27B | 1.05% | 572,003 | 7.12M |
| 75 | MBX | MBX Biosciences, Inc. | 3.23B | 1.06% | 545,470 | - |
| 76 | QURE | uniQure N.V. | 3.22B | 2.34% | 1,827,795 | 18.67M |
| 77 | ARQT | Arcutis Biotherapeutics, Inc. | 3.18B | -4.31% | 2,448,556 | 463.98M |
| 78 | IRON | Disc Medicine, Inc. | 2.97B | -0.14% | 307,548 | - |
| 79 | IOVA | Iovance Biotherapeutics, Inc. | 2.87B | 2.09% | 30,970,672 | 324.97M |
| 80 | TARS | Tarsus Pharmaceuticals, Inc. | 2.84B | -0.83% | 983,149 | 606.33M |
| 81 | IMNM | Immunome, Inc. | 2.83B | -3.06% | 772,555 | 4.02M |
| 82 | KOD | Kodiak Sciences Inc. | 2.83B | -0.07% | 511,436 | - |
| 83 | BEAM | Beam Therapeutics Inc. | 2.75B | 0.84% | 1,323,930 | 156.04M |
| 84 | ATAI | AtaiBeckley Inc. | 2.68B | 0.97% | 6,407,456 | 3.49M |
| 85 | NRIX | Nurix Therapeutics, Inc. | 2.65B | 1.23% | 729,851 | 36.77M |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.63B | 0.05% | 2,194,680 | - |
| 87 | ZLAB | Zai Lab Limited | 2.62B | 11.69% | 2,046,120 | 449.61M |
| 88 | VRDN | Viridian Therapeutics, Inc. | 2.60B | 4.80% | 1,659,798 | 71.13M |
| 89 | PGEN | Precigen, Inc. | 2.59B | 4.63% | 5,758,900 | 85.72M |
| 90 | NKTR | Nektar Therapeutics | 2.58B | 4.13% | 899,043 | 55.63M |
| 91 | RARE | Ultragenyx Pharmaceutical Inc. | 2.55B | 0.35% | 3,808,975 | 717.00M |
| 92 | PHVS | Pharvaris N.V. | 2.44B | 1.34% | 696,380 | - |
| 93 | KLRA | Kailera Therapeutics, Inc. | 2.42B | -1.11% | 276,237 | - |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 1.33% | 386,166 | - |
| 95 | SLS | SELLAS Life Sciences Group, Inc. | 2.36B | 2.65% | 5,124,094 | - |
| 96 | VERA | Vera Therapeutics, Inc. | 2.36B | 2.72% | 1,515,195 | - |
| 97 | COAG | Hemab Therapeutics Holdings, Inc. | 2.32B | -4.79% | 415,712 | - |
| 98 | NUVB | Nuvation Bio Inc. | 2.32B | 8.02% | 5,777,358 | 169.90M |
| 99 | VCEL | Vericel Corporation | 2.31B | 0.63% | 443,885 | 306.30M |
| 100 | SION | Sionna Therapeutics, Inc. | 2.30B | 2.88% | 747,526 | - |
| 101 | URGN | UroGen Pharma Ltd. | 2.30B | 2.98% | 1,026,471 | 188.73M |
| 102 | PVLA | Palvella Therapeutics, Inc. | 2.27B | 1.83% | 182,279 | - |
| 103 | HRMY | Harmony Biosciences Holdings, Inc. | 2.24B | -0.88% | 994,522 | 959.90M |
| 104 | ADMA | ADMA Biologics, Inc. | 2.22B | -1.59% | 3,305,138 | 512.28M |
| 105 | BHVN | Biohaven Ltd. | 2.21B | 1.66% | 1,121,813 | - |
| 106 | RAPP | Rapport Therapeutics, Inc. | 2.18B | -1.86% | 246,052 | 20.00M |
| 107 | ABCL | AbCellera Biologics Inc. | 2.12B | 6.13% | 6,822,768 | 66.17M |
| 108 | STOK | Stoke Therapeutics, Inc. | 2.11B | 2.44% | 866,577 | 27.59M |
| 109 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | -1.74% | 1,545,125 | 311.51M |
| 110 | TSHA | Taysha Gene Therapies, Inc. | 2.10B | 3.47% | 1,929,723 | 7.47M |
| 111 | GHRS | GH Research PLC | 2.08B | -1.21% | 337,142 | - |
| 112 | MESO | Mesoblast Limited | 2.05B | 2.18% | 80,929 | 65.38M |
| 113 | ZBIO | Zenas BioPharma, Inc. | 2.05B | 0.81% | 263,866 | 10.00M |
| 114 | OCUL | Ocular Therapeutix, Inc. | 2.02B | 5.15% | 2,016,573 | 52.06M |
| 115 | NBTX | Nanobiotix S.A. | 1.96B | 1.14% | 107,384 | 38.27M |
| 116 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 1.00% | 1,178,848 | 98.34M |
| 117 | BRVE | Braveheart Bio, Inc. | 1.93B | 0.67% | 566,321 | - |
| 118 | FBRX | Forte Biosciences, Inc. | 1.88B | -0.05% | 1,056,673 | - |
| 119 | BCAX | Bicara Therapeutics Inc. | 1.84B | 2.00% | 570,507 | - |
| 120 | DMRA | Damora Therapeutics, Inc. | 1.84B | 0.13% | 197,354 | - |
| 121 | GENB | Generate Biomedicines, Inc. | 1.84B | 3.31% | 505,790 | 26.48M |
| 122 | KARD | Kardigan, Inc. | 1.83B | 0.69% | 160,029 | - |
| 123 | SNDX | Syndax Pharmaceuticals, Inc. | 1.82B | 3.24% | 1,188,303 | 252.25M |
| 124 | LKFT | Lakefront Biotherapeutics NV | 1.78B | 3.33% | 139,062 | 1.20B |
| 125 | SRPT | Sarepta Therapeutics, Inc. | 1.77B | - | 3,064,108 | 1.97B |
| 126 | FTRE | Fortrea Holdings Inc. | 1.75B | 4.18% | 989,727 | 2.68B |
| 127 | SEPN | Septerna, Inc. | 1.75B | -1.77% | 274,144 | 72.26M |
| 128 | IMCR | Immunocore Holdings plc | 1.73B | -1.36% | 492,085 | 430.78M |
| 129 | RXRX | Recursion Pharmaceuticals, Inc. | 1.73B | 1.26% | 9,355,889 | 54.86M |
| 130 | AAPG | Ascentage Pharma Group International | 1.71B | 11.09% | 8,680 | 82.08M |
| 131 | OBX | Obsidian Therapeutics, Inc. | 1.70B | -3.00% | 8,857 | - |
| 132 | ZYME | Zymeworks Inc. | 1.69B | 1.77% | 546,559 | 37.13M |
| 133 | ANAB | AnaptysBio, Inc. | 1.68B | 3.36% | 536,732 | 232.39M |
| 134 | NTLA | Intellia Therapeutics, Inc. | 1.67B | 6.23% | 4,937,181 | 59.51M |
| 135 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.61B | -0.32% | 4,077,469 | 208.78M |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.59B | 0.42% | 480,729 | 20.00M |
| 137 | TYRA | Tyra Biosciences, Inc. | 1.58B | -1.67% | 820,623 | - |
| 138 | TRAX | First Tracks Biotherapeutics, Inc. | 1.58B | 0.04% | 629,281 | - |
| 139 | XNCR | Xencor, Inc. | 1.55B | 4.05% | 1,124,577 | 104.97M |
| 140 | ABSI | Absci Corporation | 1.51B | 7.59% | 2,193,432 | 1.84M |
| 141 | MLTX | MoonLake Immunotherapeutics | 1.51B | 1.28% | 902,055 | - |
| 142 | AVLN | Avalyn Pharma Inc. | 1.50B | 3.73% | 120,903 | - |
| 143 | VIR | Vir Biotechnology, Inc. | 1.49B | 0.57% | 1,663,110 | 303.23M |
| 144 | INVA | Innoviva, Inc. | 1.48B | -2.84% | 1,143,223 | 440.00M |
| 145 | SVRA | Savara Inc. | 1.48B | 0.69% | 1,586,202 | - |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.44B | -0.55% | 302,081 | - |
| 147 | ORIC | ORIC Pharmaceuticals, Inc. | 1.40B | 4.41% | 1,330,662 | - |
| 148 | LBRX | LB Pharmaceuticals Inc | 1.38B | -0.37% | 269,158 | - |
| 149 | GLUE | Monte Rosa Therapeutics, Inc. | 1.34B | 1.08% | 1,031,389 | 28.73M |
| 150 | AKTS | Aktis Oncology, Inc. | 1.33B | 2.94% | 154,636 | 8.28M |
| 151 | MNKD | MannKind Corporation | 1.32B | 5.66% | 5,048,092 | 393.63M |
| 152 | IMTX | Immatics N.V. | 1.32B | 2.44% | 309,302 | 43.00M |
| 153 | NVAX | Novavax, Inc. | 1.31B | 2.71% | 5,704,173 | 413.80M |
| 154 | JBIO | Jade Biosciences, Inc. | 1.30B | -1.26% | 481,233 | - |
| 155 | INBX | Inhibrx Biosciences, Inc. | 1.30B | 3.35% | 407,403 | 1.30M |
| 156 | VOR | Vor Biopharma Inc. | 1.28B | -0.13% | 801,804 | - |
| 157 | SPTX | Seaport Therapeutics, Inc. | 1.26B | 2.30% | 112,371 | - |
| 158 | MGTX | MeiraGTx Holdings plc | 1.21B | 2.19% | 300,120 | 79.76M |
| 159 | WVE | Wave Life Sciences Ltd. | 1.20B | 1.33% | 4,556,371 | 65.37M |
| 160 | EYPT | EyePoint, Inc. | 1.20B | 8.26% | 1,655,691 | 2.79M |
| 161 | DRTS | Alpha Tau Medical Ltd. | 1.19B | 1.15% | 297,025 | - |
| 162 | CRVS | Corvus Pharmaceuticals, Inc. | 1.17B | 0.43% | 1,370,029 | - |
| 163 | IVA | Inventiva S.A. | 1.16B | 3.00% | 579,057 | 7.94M |
| 164 | LTGO | Latigo Biotherapeutics, Inc. | 1.15B | 1.39% | 3,303,862 | - |
| 165 | ANRO | Alto Neuroscience, Inc. | 1.11B | 0.70% | 336,431 | - |
| 166 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.10B | 4.66% | 3,085,709 | 41.47M |
| 167 | CGEM | Cullinan Therapeutics, Inc. | 1.09B | -1.23% | 361,727 | - |
| 168 | APMD | Apnimed, Inc. | 1.08B | -3.16% | 160,472 | 120.15M |
| 169 | SANA | Sana Biotechnology, Inc. | 1.06B | 3.23% | 2,153,476 | - |
| 170 | OLMA | Olema Pharmaceuticals, Inc. | 1.05B | 2.12% | 757,195 | - |
| 171 | ODTX | Odyssey Therapeutics, Inc. | 1.01B | -1.76% | 97,817 | 99.00K |
| 172 | REPL | Replimune Group, Inc. | 1.01B | -6.22% | 8,913,757 | - |
| 173 | ARDX | Ardelyx, Inc. | 988.12M | -17.86% | 20,070,394 | 450.89M |
| 174 | AVTX | Avalo Therapeutics, Inc. | 969.18M | -2.03% | 730,168 | 59.00K |
| 175 | JANX | Janux Therapeutics, Inc. | 966.60M | -1.55% | 625,334 | 24.00M |
| 176 | OMER | Omeros Corporation | 958.97M | 0.76% | 1,227,715 | 9.89M |
| 177 | GERN | Geron Corporation | 950.86M | -5.73% | 8,885,427 | 204.56M |
| 178 | ABUS | Arbutus Biopharma Corporation | 914.60M | 1.98% | 796,029 | 191.45M |
| 179 | ANNX | Annexon, Inc. | 886.39M | -3.39% | 1,784,136 | - |
| 180 | AURA | Aura Biosciences, Inc. | 881.29M | 3.50% | 538,188 | - |
| 181 | TBPH | Theravance Biopharma, Inc. | 877.45M | 0.06% | 2,722,733 | 109.78M |
| 182 | DSGN | Design Therapeutics, Inc. | 875.52M | 1.60% | 418,867 | - |
| 183 | ATTO | Attovia Therapeutics, Inc. | 867.90M | -1.03% | 237,906 | 1.35M |
| 184 | KURA | Kura Oncology, Inc. | 849.57M | 3.13% | 749,257 | 71.64M |
| 185 | SGP | SpyGlass Pharma, Inc. | 846.20M | 2.26% | 72,029 | - |
| 186 | SLDB | Solid Biosciences Inc. | 825.99M | -3.67% | 1,054,878 | - |
| 187 | ACRS | Aclaris Therapeutics, Inc. | 825.41M | -2.96% | 2,388,047 | 8.22M |
| 188 | CLYM | Climb Bio, Inc. | 801.68M | - | 910,241 | - |
| 189 | MNPR | Monopar Therapeutics Inc. | 798.56M | -0.83% | 223,297 | - |
| 190 | DBVT | DBV Technologies S.A. | 795.72M | -1.89% | 698,713 | 5.04M |
| 191 | PHAR | Pharming Group N.V. | 785.51M | 0.92% | 6,392 | 366.48M |
| 192 | DRUG | Bright Minds Biosciences Inc. | 781.58M | -1.82% | 156,403 | - |
| 193 | CADL | Candel Therapeutics, Inc. | 775.93M | 0.09% | 800,783 | - |
| 194 | TENX | Tenax Therapeutics, Inc. | 769.87M | 0.98% | 2,092,742 | - |
| 195 | OCS | Oculis Holding AG | 765.72M | 2.02% | 370,877 | 1.45M |
| 196 | CTMX | CytomX Therapeutics, Inc. | 753.25M | 2.67% | 2,461,728 | 18.30M |
| 197 | RIGL | Rigel Pharmaceuticals, Inc. | 750.37M | 2.42% | 315,499 | 276.79M |
| 198 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 747.40M | 6.26% | 219,391 | - |
| 199 | GYRE | Gyre Therapeutics, Inc. | 743.63M | 4.22% | 68,092 | 109.82M |
| 200 | CBIO | Crescent Biopharma, Inc. | 720.77M | 2.50% | 150,667 | 11.88M |
| 201 | HELP | Cybin Inc. | 719.64M | 4.59% | 1,737,859 | - |
| 202 | AGMB | AgomAb Therapeutics NV | 714.10M | 7.41% | 367,400 | - |
| 203 | NGNE | Neurogene Inc. | 711.19M | 0.25% | 103,220 | 925.00K |
| 204 | ALLO | Allogene Therapeutics, Inc. | 693.76M | 2.03% | 3,698,152 | 22.00K |
| 205 | IMMX | Immix Biopharma, Inc. | 691.97M | -3.38% | 1,604,783 | - |
| 206 | ZVRA | Zevra Therapeutics, Inc. | 686.48M | -2.69% | 1,262,784 | 136.07M |
| 207 | ACHV | Achieve Life Sciences, Inc. | 682.68M | 1.53% | 712,458 | - |
| 208 | PHAT | Phathom Pharmaceuticals, Inc. | 679.13M | 1.91% | 2,311,288 | 239.66M |
| 209 | RGNX | REGENXBIO Inc. | 661.45M | -4.96% | 1,387,934 | 174.48M |
| 210 | MDXG | MiMedx Group, Inc. | 632.60M | 3.83% | 1,361,859 | 355.17M |
| 211 | FTH | Faeth Therapeutics, Inc. | 628.74M | -0.37% | 202,840 | - |
| 212 | NVCT | Nuvectis Pharma, Inc. | 617.42M | 0.64% | 171,936 | - |
| 213 | SPRY | ARS Pharmaceuticals, Inc. | 611.71M | 10.99% | 2,155,794 | 98.99M |
| 214 | ALT | Altimmune, Inc. | 598.98M | 2.33% | 4,505,570 | 36.00K |
| 215 | VSTM | Verastem, Inc. | 592.27M | 14.04% | 4,319,009 | 87.53M |
| 216 | TECX | Tectonic Therapeutic, Inc. | 584.57M | 2.51% | 271,635 | - |
| 217 | CRMD | CorMedix Inc. | 583.68M | -0.93% | 740,859 | 400.05M |
| 218 | ARVN | Arvinas, Inc. | 572.13M | 0.81% | 1,218,172 | 316.70M |
| 219 | ZURA | Zura Bio Limited | 566.66M | 4.47% | 955,896 | - |
| 220 | CTNM | Contineum Therapeutics, Inc. | 565.82M | -2.02% | 528,931 | - |
| 221 | SLN | Silence Therapeutics plc | 564.45M | 1.96% | 316,885 | 839.00K |
| 222 | FDMT | 4D Molecular Therapeutics, Inc. | 561.97M | 1.90% | 346,898 | 88.24M |
| 223 | AUTL | Autolus Therapeutics plc | 561.56M | 5.50% | 2,035,534 | 92.62M |
| 224 | SGMT | Sagimet Biosciences Inc. | 559.47M | 3.66% | 1,113,003 | - |
| 225 | STTK | Shattuck Labs, Inc. | 557.47M | 1.54% | 894,438 | 1.00M |
| 226 | PRME | Prime Medicine, Inc. | 556.30M | 4.41% | 1,976,941 | 4.07M |
| 227 | MPLT | MapLight Therapeutics, Inc. | 551.86M | -8.36% | 432,478 | - |
| 228 | ARTV | Artiva Biotherapeutics, Inc. | 547.59M | -2.68% | 214,658 | 251.00K |
| 229 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.70M | -6.24% | 1,653,527 | 132.42M |
| 230 | ANL | Adlai Nortye Ltd. | 531.20M | -4.05% | 270,000 | 5.00M |
| 231 | RLMD | Relmada Therapeutics, Inc. | 518.16M | -8.01% | 2,125,224 | - |
| 232 | ASMB | Assembly Biosciences, Inc. | 513.62M | 0.87% | 119,771 | 71.10M |
| 233 | EVMN | Evommune, Inc. | 507.14M | 5.23% | 374,001 | 10.00M |
| 234 | EIKN | Eikon Therapeutics, Inc. | 502.95M | 0.87% | 662,404 | - |
| 235 | VALN | Valneva SE | 496.81M | 2.32% | 44,235 | 180.25M |
| 236 | PROK | ProKidney Corp. | 495.38M | - | 739,044 | 889.00K |
| 237 | OVID | Ovid Therapeutics Inc. | 490.86M | -0.75% | 919,697 | 7.12M |
| 238 | SCTX | Scribe Therapeutics Inc. | 490.47M | 2.32% | 120,159 | 36.28M |
| 239 | BLSM | BlossomHill Therapeutics, Inc. | 490.30M | - | 1,757,634 | - |
| 240 | RZLT | Rezolute, Inc. | 489.95M | -0.21% | 986,250 | - |
| 241 | PRLD | Prelude Therapeutics Incorporated | 485.97M | 4.70% | 165,656 | 16.72M |
| 242 | KYTX | Kyverna Therapeutics, Inc. | 483.93M | 2.71% | 431,844 | - |
| 243 | IKT | Inhibikase Therapeutics, Inc. | 482.69M | 2.49% | 386,846 | 1.00 |
| 244 | BNTC | Benitec Biopharma Inc. | 468.25M | 3.81% | 41,160 | - |
| 245 | QTTB | Q32 Bio Inc. | 464.32M | -3.70% | 513,378 | 53.74M |
| 246 | PBYI | Puma Biotechnology, Inc. | 459.93M | 9.73% | 683,332 | 231.24M |
| 247 | PRTA | Prothena Corporation plc | 458.61M | 2.10% | 481,846 | 54.53M |
| 248 | CABA | Cabaletta Bio, Inc. | 454.92M | 1.09% | 2,697,633 | - |
| 249 | OABI | OmniAb, Inc. | 446.52M | 37.50% | 2,681,397 | 38.46M |
| 250 | EPRX | Eupraxia Pharmaceuticals Inc. | 443.40M | 1.65% | 475,829 | - |
| 251 | EDIT | Editas Medicine, Inc. | 441.97M | -0.69% | 1,692,929 | 47.01M |
| 252 | VTVT | vTv Therapeutics Inc. | 438.92M | 1.08% | 147,517 | 36.84M |
| 253 | XFOR | X4 Pharmaceuticals, Inc. | 437.64M | 11.27% | 1,597,330 | 15.85M |
| 254 | LRMR | Larimar Therapeutics, Inc. | 434.23M | -0.95% | 631,187 | - |
| 255 | OCGN | Ocugen, Inc. | 433.31M | 3.23% | 4,537,422 | 4.47M |
| 256 | SLBT | SL Science Holding Limited | 431.54M | -2.20% | 26,359 | 3.27M |
| 257 | STRO | Sutro Biopharma, Inc. | 420.56M | 5.09% | 169,335 | 99.61M |
| 258 | AVIR | Atea Pharmaceuticals, Inc. | 420.14M | 5.21% | 264,991 | - |
| 259 | ABEO | Abeona Therapeutics Inc. | 412.64M | 4.93% | 1,396,682 | 14.54M |
| 260 | CCCC | C4 Therapeutics, Inc. | 412.42M | 2.47% | 1,469,442 | 34.86M |
| 261 | FENC | Fennec Pharmaceuticals Inc. | 402.08M | 6.78% | 226,652 | 51.00M |
| 262 | ENTA | Enanta Pharmaceuticals, Inc. | 400.41M | 3.22% | 182,990 | 69.21M |
| 263 | UPB | Upstream Bio, Inc. | 394.54M | 5.53% | 621,836 | 3.32M |
| 264 | RCKT | Rocket Pharmaceuticals, Inc. | 394.19M | 1.98% | 1,321,924 | - |
| 265 | CMPX | Compass Therapeutics, Inc. | 387.19M | 8.04% | 3,827,182 | 850.00K |
| 266 | LXEO | Lexeo Therapeutics, Inc. | 377.69M | 5.71% | 1,080,243 | - |
| 267 | PALI | Palisade Bio, Inc. | 366.25M | 0.96% | 886,446 | - |
| 268 | DMAC | DiaMedica Therapeutics Inc. | 363.71M | -0.30% | 109,223 | - |
| 269 | IPSC | Century Therapeutics, Inc. | 360.71M | 5.26% | 522,583 | 109.16M |
| 270 | LYEL | Lyell Immunopharma, Inc. | 360.46M | 3.52% | 110,955 | 27.00K |
| 271 | FHTX | Foghorn Therapeutics Inc. | 356.39M | 8.98% | 280,894 | 36.74M |
| 272 | VCRE | Vicore Pharma Holding AB (publ) | 340.42M | 1.10% | 760 | 370.61K |
| 273 | CUVL | Clinuvel Pharmaceuticals Limited | 336.21M | -0.67% | 2,843 | 64.24M |
| 274 | FATE | Fate Therapeutics, Inc. | 326.37M | 12.45% | 4,015,589 | 6.32M |
| 275 | AGEN | Agenus Inc. | 311.48M | -7.08% | 1,190,351 | 132.69M |
| 276 | TTRX | Turn Therapeutics Inc. | 310.09M | 8.32% | 88,739 | - |
| 277 | AVXL | Anavex Life Sciences Corp. | 309.52M | 1.83% | 1,045,864 | - |
| 278 | VNDA | Vanda Pharmaceuticals Inc. | 302.31M | -2.34% | 1,306,431 | 215.72M |
| 279 | IRD | Opus Genetics, Inc. | 302.19M | -1.61% | 915,122 | 9.86M |
| 280 | NMRA | Neumora Therapeutics, Inc. | 302.01M | -0.61% | 687,280 | - |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 300.41M | -15.60% | 1,578,410 | 26.87M |
| 282 | SABS | SAB Biotherapeutics, Inc. | 298.21M | 1.30% | 343,906 | 114.70K |
| 283 | SRZN | Surrozen, Inc. | 297.46M | 18.39% | 371,171 | 11.51M |
| 284 | FULC | Fulcrum Therapeutics, Inc. | 296.80M | 3.18% | 1,460,083 | 80.00M |
| 285 | IMRX | Immuneering Corporation | 291.79M | 1.12% | 723,266 | - |
| 286 | BCYC | Bicycle Therapeutics plc | 291.11M | 5.04% | 288,647 | 61.21M |
| 287 | SLGL | Sol-Gel Technologies Ltd. | 287.67M | 1.27% | 46,381 | 18.47M |
| 288 | ELDN | Eledon Pharmaceuticals, Inc. | 285.25M | 6.65% | 929,879 | - |
| 289 | ALXO | ALX Oncology Holdings Inc. | 282.58M | -0.47% | 8,489,895 | - |
| 290 | LCTX | Lineage Cell Therapeutics, Inc. | 274.23M | -2.65% | 833,645 | 13.08M |
| 291 | ADAG | Adagene Inc. | 271.56M | -0.72% | 285,510 | 7.67M |
| 292 | IFRX | InflaRx N.V. | 271.02M | 6.98% | 1,167,411 | -11.54K |
| 293 | PRQR | ProQR Therapeutics N.V. | 264.60M | -1.32% | 558,945 | 15.73M |
| 294 | RNAC | Cartesian Therapeutics, Inc. | 260.03M | 1.03% | 84,113 | 1.48M |
| 295 | MGNX | MacroGenics, Inc. | 256.80M | 0.75% | 296,657 | 157.08M |
| 296 | WHWK | Whitehawk Therapeutics, Inc. | 256.01M | 1.28% | 600,056 | 7.15M |
| 297 | OBIO | Orchestra BioMed Holdings, Inc. | 253.89M | 2.17% | 103,915 | 32.72M |
| 298 | TRDA | Entrada Therapeutics, Inc. | 247.71M | - | 376,952 | 4.69M |
| 299 | NAGE | Niagen Bioscience, Inc. | 247.39M | 2.63% | 889,773 | 129.08M |
| 300 | CAPR | Capricor Therapeutics, Inc. | 236.86M | -2.15% | 3,617,849 | 11.13M |
| 301 | PYXS | Pyxis Oncology, Inc. | 236.32M | -0.53% | 1,242,034 | 13.86M |
| 302 | ACIU | AC Immune SA | 234.11M | 1.72% | 76,941 | 21.67M |
| 303 | TARA | Protara Therapeutics, Inc. | 231.56M | 0.49% | 340,648 | - |
| 304 | CGEN | Compugen Ltd. | 228.29M | 4.78% | 276,177 | 74.00M |
| 305 | GALT | Galectin Therapeutics Inc. | 227.21M | 7.14% | 329,200 | - |
| 306 | KROS | Keros Therapeutics, Inc. | 221.07M | 4.69% | 319,628 | 15.01M |
| 307 | CAMP | Camp4 Therapeutics Corporation | 220.17M | -5.78% | 95,101 | 3.93M |
| 308 | IVVD | Invivyd, Inc. | 218.01M | 12.29% | 3,515,931 | 55.87M |
| 309 | CNXU | Conexeu Sciences Inc. | 215.94M | -4.72% | 118,419 | - |
| 310 | ANTX | AN2 Therapeutics, Inc. | 213.58M | -2.47% | 124,473 | - |
| 311 | RNA | Atrium Therapeutics, Inc. | 211.08M | 1.90% | 103,281 | 36.68M |
| 312 | GLSI | Greenwich LifeSciences, Inc. | 210.78M | 0.84% | 88,484 | - |
| 313 | ARCT | Arcturus Therapeutics Holdings Inc. | 210.61M | 21.88% | 1,461,520 | 29.37M |
| 314 | NBP | NovaBridge Biosciences | 202.38M | 2.94% | 178,259 | - |
| 315 | CLLS | Cellectis S.A. | 202.28M | 5.39% | 24,094 | 63.82M |
| 316 | NERV | Minerva Neurosciences, Inc. | 198.93M | -3.83% | 171,005 | - |
| 317 | ACOG | Alpha Cognition Inc. | 198.80M | 5.31% | 30,651 | 10.83M |
| 318 | PLX | Protalix BioTherapeutics, Inc. | 198.21M | 0.82% | 670,214 | 76.38M |
| 319 | ALEC | Alector, Inc. | 197.62M | -2.73% | 1,246,975 | 13.86M |
| 320 | VYGR | Voyager Therapeutics, Inc. | 197.58M | 4.47% | 469,232 | 34.46M |
| 321 | PEPG | PepGen Inc. | 197.13M | 18.26% | 3,223,997 | - |
| 322 | CHRS | Coherus Oncology, Inc. | 195.90M | 0.40% | 1,600,214 | 50.94M |
| 323 | IMUX | Immunic, Inc. | 194.79M | -1.65% | 175,602 | - |
| 324 | HUMA | Humacyte, Inc. | 193.65M | 1.21% | 2,277,637 | 2.02M |
| 325 | DTIL | Precision BioSciences, Inc. | 193.26M | 0.94% | 240,102 | 45.06M |
| 326 | TNXP | Tonix Pharmaceuticals Holding Corp. | 191.77M | 3.26% | 387,870 | 17.56M |
| 327 | KRRO | Korro Bio, Inc. | 191.10M | 9.32% | 119,893 | 2.38M |
| 328 | OTLK | Outlook Therapeutics, Inc. | 190.74M | 4.88% | 4,560,324 | 333.14K |
| 329 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 188.43M | 4.41% | 357,094 | - |
| 330 | MDWD | MediWound Ltd. | 184.94M | 0.77% | 58,565 | 14.48M |
| 331 | NGEN | NervGen Pharma Corp. | 181.97M | -0.58% | 278,108 | - |
| 332 | ABOS | Acumen Pharmaceuticals, Inc. | 176.24M | 7.02% | 256,798 | - |
| 333 | ORMP | Oramed Pharmaceuticals Inc. | 175.98M | - | 110,531 | 2.00M |
| 334 | ARMP | Armata Pharmaceuticals, Inc. | 172.91M | 0.21% | 37,501 | 5.20M |
| 335 | NKTX | Nkarta, Inc. | 172.42M | 5.24% | 531,232 | - |
| 336 | AARD | Aardvark Therapeutics, Inc. | 172.35M | 8.22% | 74,642 | - |
| 337 | LENZ | LENZ Therapeutics, Inc. | 168.06M | 2.68% | 452,762 | 20.99M |
| 338 | OKUR | OnKure Therapeutics, Inc. | 167.65M | -0.24% | 85,008 | - |
| 339 | MIST | Milestone Pharmaceuticals Inc. | 165.98M | 3.39% | 990,171 | 1.78M |
| 340 | IPHA | Innate Pharma S.A. | 163.74M | -3.08% | 5,017 | 10.57M |
| 341 | CRBU | Caribou Biosciences, Inc. | 163.65M | 0.61% | 806,038 | 11.20M |
| 342 | YDES | YD Bio Limited | 161.38M | -2.92% | 27,708 | 510.36K |
| 343 | KZIA | Kazia Therapeutics Limited | 158.66M | 12.61% | 295,125 | 1.27M |
| 344 | CDXS | Codexis, Inc. | 158.12M | -0.68% | 764,654 | 78.09M |
| 345 | TNYA | Tenaya Therapeutics, Inc. | 157.71M | 0.14% | 1,600,384 | 1.34M |
| 346 | MENS | Jyong Biotech Ltd. | 150.69M | 0.50% | 38,865 | - |
| 347 | MOLN | Molecular Partners AG | 150.46M | 1.48% | 142 | 856.30K |
| 348 | NRXP | NRx Pharmaceuticals, Inc. | 150.04M | 15.86% | 5,676,501 | 2.29M |
| 349 | CNTN | Canton Strategic Holdings, Inc. | 144.22M | 0.54% | 571,799 | - |
| 350 | ENTX | Entera Bio Ltd. | 141.46M | 1.77% | 244,910 | 42.00K |
| 351 | UNCY | Unicycive Therapeutics, Inc. | 138.88M | 0.40% | 509,095 | - |
| 352 | CNTB | Connect Biopharma Holdings Limited | 138.84M | 0.68% | 337,477 | 233.00K |
| 353 | CBUS | Cibus, Inc. | 138.16M | -3.21% | 163,621 | 4.29M |
| 354 | HURA | TuHURA Biosciences, Inc. | 135.64M | 0.71% | 66,724 | - |
| 355 | INDP | Indaptus Therapeutics, Inc. | 133.63M | -5.60% | 130,799 | - |
| 356 | EQ | Equillium, Inc. | 133.41M | -0.47% | 406,583 | 4.39M |
| 357 | PMN | ProMIS Neurosciences, Inc. | 131.91M | 10.35% | 27,616 | - |
| 358 | TLSA | Tiziana Life Sciences Ltd | 129.31M | 2.64% | 982,253 | - |
| 359 | SPRB | Spruce Biosciences, Inc. | 129.00M | 0.97% | 33,989 | 697.00K |
| 360 | VANI | Vivani Medical, Inc. | 121.59M | 3.68% | 195,688 | - |
| 361 | ENGN | enGene Therapeutics Inc. | 120.58M | - | 351,626 | - |
| 362 | SEER | Seer, Inc. | 119.31M | -0.91% | 268,260 | 15.17M |
| 363 | GNLX | Genelux Corporation | 118.13M | -1.48% | 246,813 | 8.00K |
| 364 | ANIX | Anixa Biosciences, Inc. | 116.36M | -0.29% | 154,789 | - |
| 365 | YARW | Yarrow Bioscience, Inc. | 116.00M | -0.50% | 23,674 | - |
| 366 | NAUT | Nautilus Biotechnology, Inc. | 114.54M | 1.58% | 916,741 | 190.00K |
| 367 | CUE | Cue Biopharma, Inc. | 113.91M | 0.41% | 57,400 | 32.73M |
| 368 | COYA | Coya Therapeutics, Inc. | 112.83M | 5.02% | 141,833 | 7.94M |
| 369 | BDTX | Black Diamond Therapeutics, Inc. | 111.74M | 1.56% | 599,850 | 70.00M |
| 370 | GUTS | Fractyl Health, Inc. | 110.99M | 1.83% | 1,055,583 | 3.00K |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 108.00M | 1.40% | 202,062 | 3.17M |
| 372 | PLYX | Polaryx Therapeutics, Inc. | 107.00M | 1.80% | 69,880 | - |
| 373 | ICCC | ImmuCell Corporation | 99.51M | -0.18% | 9,704 | 29.93M |
| 374 | PTHS | Pelthos Therapeutics Inc. | 98.57M | -3.70% | 42,086 | 27.70M |
| 375 | KLRS | Kalaris Therapeutics, Inc. | 97.07M | -2.63% | 58,830 | - |
| 376 | CGTX | Cognition Therapeutics, Inc. | 96.66M | -4.42% | 901,705 | - |
| 377 | ONCY | Oncolytics Biotech Inc. | 95.78M | 0.24% | 571,217 | - |
| 378 | ALDX | Aldeyra Therapeutics, Inc. | 93.50M | -2.52% | 1,171,166 | - |
| 379 | HRTX | Heron Therapeutics, Inc. | 92.90M | -1.64% | 2,131,204 | 150.71M |
| 380 | PYPD | PolyPid Ltd. | 92.80M | 0.62% | 143,979 | - |
| 381 | BMEA | Biomea Fusion, Inc. | 91.10M | 0.80% | 426,622 | - |
| 382 | NTHI | NeOnc Technologies Holdings, Inc. | 90.77M | - | 51,095 | 39.99K |
| 383 | FBIO | Fortress Biotech, Inc. | 88.69M | -3.61% | 579,970 | 66.16M |
| 384 | NRXS | NeurAxis, Inc. | 87.81M | 2.31% | 44,782 | 4.28M |
| 385 | VRCA | Verrica Pharmaceuticals Inc. | 87.27M | -5.22% | 126,327 | 30.32M |
| 386 | GOSS | Gossamer Bio, Inc. | 87.01M | -0.22% | 10,940,334 | 55.54M |
| 387 | MAIA | MAIA Biotechnology, Inc. | 86.34M | - | 333,250 | - |
| 388 | RLYB | Rallybio Corporation | 85.62M | -0.19% | 12,300 | 646.00K |
| 389 | ACET | Adicet Bio, Inc. | 83.80M | 0.63% | 80,387 | - |
| 390 | ANVS | Annovis Bio, Inc. | 79.98M | 1.08% | 557,219 | - |
| 391 | TELO | Telomir Pharmaceuticals, Inc. | 79.78M | -0.85% | 11,351 | - |
| 392 | ATHE | Alterity Therapeutics Limited | 79.11M | -2.41% | 1,394 | 4.43M |
| 393 | OKYO | OKYO Pharma Limited | 78.19M | -2.93% | 105,532 | - |
| 394 | GANX | Gain Therapeutics, Inc. | 77.63M | 2.25% | 342,902 | - |
| 395 | ATRA | Atara Biotherapeutics, Inc. | 76.14M | 2.42% | 23,212 | 23.14M |
| 396 | ELTX | Elicio Therapeutics, Inc. | 74.81M | 1.59% | 122,255 | - |
| 397 | ACRV | Acrivon Therapeutics, Inc. | 74.05M | 2.37% | 302,238 | - |
| 398 | INO | Inovio Pharmaceuticals, Inc. | 73.24M | -0.86% | 3,051,039 | 65.34K |
| 399 | SPRO | Spero Therapeutics, Inc. | 72.96M | -0.79% | 459,005 | 61.19M |
| 400 | LONA | LeonaBio, Inc. | 72.33M | -1.41% | 34,987 | - |
| 401 | CSBR | Champions Oncology, Inc. | 72.11M | - | 4,794 | 59.43M |
| 402 | CING | Cingulate Inc. | 71.92M | 5.74% | 217,394 | - |
| 403 | OSTX | OS Therapies Incorporated | 71.26M | -1.84% | 289,417 | - |
| 404 | ELOX | Eloxx Pharmaceuticals, Inc. | 70.92M | -0.79% | 32,401 | - |
| 405 | IBIO | iBio, Inc. | 70.05M | 1.44% | 436,394 | 300.00K |
| 406 | RNTX | Rein Therapeutics Inc. | 69.93M | 3.68% | 361,286 | - |
| 407 | XBIT | XBiotech Inc. | 69.21M | -0.44% | 15,352 | - |
| 408 | ALPS | Alps Group Inc | 69.07M | 0.02% | 15,613 | 3.74M |
| 409 | CRDF | Cardiff Oncology, Inc. | 67.82M | 3.28% | 639,391 | 525.00K |
| 410 | MNOV | MediciNova, Inc. | 65.96M | -1.47% | 11,380 | 596.64K |
| 411 | BOLD | Boundless Bio, Inc. | 65.03M | 1.94% | 940,375 | - |
| 412 | PLRX | Pliant Therapeutics, Inc. | 65.02M | - | 310,272 | - |
| 413 | IMA | ImageneBio, Inc. | 63.84M | 0.53% | 32,305 | 800.00K |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 63.46M | 0.85% | 117,948 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 61.55M | 2.34% | 112,846 | 11.43M |
| 416 | DWTX | Dogwood Therapeutics, Inc. | 60.70M | 3.14% | 5,739 | - |
| 417 | INMB | INmune Bio Inc. | 55.43M | 9.16% | 953,027 | 50.00K |
| 418 | XLO | Xilio Therapeutics, Inc. | 54.86M | -1.08% | 11,519 | 53.48M |
| 419 | INKT | MiNK Therapeutics, Inc. | 54.55M | -0.45% | 4,723 | - |
| 420 | TCRX | TScan Therapeutics, Inc. | 52.03M | 4.32% | 336,330 | 9.14M |
| 421 | EDSA | Edesa Biotech, Inc. | 50.77M | 4.36% | 54,598 | - |
| 422 | RNXT | RenovoRx, Inc. | 50.51M | -2.61% | 317,826 | 1.49M |
| 423 | TIL | Instil Bio, Inc. | 50.25M | 1.79% | 11,759 | - |
| 424 | VRXA | Veraxa Biotech AG | 50.18M | 6.99% | 155,525 | - |
| 425 | ATYR | aTyr Pharma, Inc. | 50.14M | 1.87% | 369,833 | 190.00K |
| 426 | IMMP | Immutep Limited | 49.96M | 2.85% | 66,443 | 5.28M |
| 427 | FLNA | Filana Therapeutics, Inc. | 48.07M | 3.75% | 614,763 | - |
| 428 | KPTI | Karyopharm Therapeutics Inc. | 48.05M | 8.72% | 1,792,750 | 151.12M |
| 429 | MREO | Mereo BioPharma Group plc | 47.29M | -3.14% | 394,254 | 500.00K |
| 430 | MCRB | Seres Therapeutics, Inc. | 47.16M | 1.04% | 62,310 | 1.88M |
| 431 | IBO | Impact BioMedical Inc. | 46.91M | -3.48% | 9,360 | 35.00K |
| 432 | EXOZ | eXoZymes, Inc. | 46.51M | -1.26% | 2,938 | -700.00 |
| 433 | MGX | Metagenomi Therapeutics, Inc. | 46.31M | -0.81% | 142,970 | 22.33M |
| 434 | CNTX | Context Therapeutics Inc. | 44.47M | -3.97% | 2,427,146 | - |
| 435 | PDSB | PDS Biotechnology Corporation | 43.27M | 3.77% | 225,995 | - |
| 436 | HYPD | Hyperion DeFi, Inc. | 40.93M | 1.12% | 114,362 | 1.04M |
| 437 | CRVO | CervoMed Inc. | 38.82M | 3.99% | 194,051 | 331.30K |
| 438 | NTRB | Nutriband Inc. | 37.81M | 6.69% | 6,455 | 1.80M |
| 439 | VERU | Veru Inc. | 37.40M | 0.87% | 258,995 | 16.89M |
| 440 | APLM | Apollomics, Inc. | 37.11M | -0.59% | 7,416 | 8.84M |
| 441 | RADX | Radiopharm Theranostics Limited | 36.76M | 0.36% | 51,075 | 10.86M |
| 442 | LTRN | Lantern Pharma Inc. | 36.49M | 2.88% | 61,214 | - |
| 443 | DYAI | Dyadic International, Inc. | 36.44M | -1.96% | 88,988 | 3.81M |
| 444 | SER | Serina Therapeutics, Inc. | 35.99M | 2.13% | 26,588 | 130.00K |
| 445 | BYSI | BeyondSpring Inc. | 35.77M | - | 187,703 | 1.88M |
| 446 | GRCE | Grace Therapeutics, Inc. | 34.66M | 0.47% | 120,375 | - |
| 447 | ALGS | Aligos Therapeutics, Inc. | 34.59M | 1.45% | 335,793 | 31.52M |
| 448 | ENLV | Enlivex Ltd. | 33.43M | 5.05% | 202,031 | - |
| 449 | NNVC | NanoViricides, Inc. | 32.35M | 1.43% | 126,865 | - |
| 450 | BCTX | BriaCell Therapeutics Corp. | 31.65M | 5.51% | 153,582 | - |
| 451 | ESLA | Estrella Immunopharma, Inc. | 31.09M | -3.13% | 5,609 | - |
| 452 | LITS | Lite Strategy, Inc. | 30.88M | -2.31% | 167,160 | - |
| 453 | GNTA | Genenta Science S.p.A. | 30.67M | -0.76% | 53,976 | - |
| 454 | CVM | CEL-SCI Corporation | 30.06M | 6.83% | 249,464 | - |
| 455 | QNCX | Quince Therapeutics, Inc. | 29.53M | 2.23% | 30,240 | - |
| 456 | KYNB | Kyntra Bio, Inc. | 29.43M | 4.15% | 5,196 | 7.44M |
| 457 | TVGN | Tevogen Inc. | 27.30M | -3.55% | 10,821 | - |
| 458 | ACTU | Actuate Therapeutics, Inc. | 26.44M | -10.16% | 203,465 | - |
| 459 | EVAX | Evaxion A/S | 25.85M | 3.51% | 7,962 | 7.53M |
| 460 | ABVC | ABVC BioPharma, Inc. | 25.78M | - | 65,904 | 797.92K |
| 461 | IGC | IGC Pharma, Inc. | 25.68M | 2.68% | 460,733 | 1.11M |
| 462 | ATNM | Actinium Pharmaceuticals, Inc. | 25.02M | 1.32% | 133,317 | 35.09M |
| 463 | BRNS | Barinthus Biotherapeutics plc | 24.47M | 6.02% | 34,881 | 14.97M |
| 464 | LGVN | Longeveron Inc. | 24.20M | -0.97% | 417,747 | 1.22M |
| 465 | ALLR | Allarity Therapeutics, Inc. | 22.12M | -0.71% | 50,842 | 345.00K |
| 466 | QNTM | Quantum BioPharma Ltd. | 22.08M | 6.81% | 181,982 | - |
| 467 | PLRZ | Polyrizon Ltd. | 21.69M | 0.87% | 11,698 | - |
| 468 | NXTC | NextCure, Inc. | 21.09M | 4.47% | 316,113 | - |
| 469 | DARE | Daré Bioscience, Inc. | 20.97M | 5.26% | 91,804 | 1.16M |
| 470 | NEUP | Neuphoria Therapeutics Inc. | 20.65M | -2.05% | 9,553 | -13.27K |
| 471 | CLRB | Cellectar Biosciences, Inc. | 20.54M | 1.98% | 16,068 | - |
| 472 | COCP | Cocrystal Pharma, Inc. | 20.42M | 2.91% | 54,205 | 225.00K |
| 473 | ATOS | Atossa Therapeutics, Inc. | 20.32M | -2.48% | 78,019 | - |
| 474 | CELU | Celularity Inc. | 20.28M | 2.59% | 18,068 | 26.55M |
| 475 | JSPR | Jasper Therapeutics, Inc. | 19.86M | 9.81% | 760,645 | - |
| 476 | PLUR | Pluri Inc. | 19.64M | 0.55% | 2,439 | 1.08M |
| 477 | GRDX | GridAI Technologies Corp. | 19.40M | -4.86% | 37,972 | - |
| 478 | HOWL | Werewolf Therapeutics, Inc. | 19.30M | -1.42% | 391,139 | 21.00M |
| 479 | CTXR | Citius Pharmaceuticals, Inc. | 18.73M | 6.28% | 442,461 | 5.61M |
| 480 | MRKR | Marker Therapeutics, Inc. | 18.67M | - | 40,085 | 3.55M |
| 481 | SKYE | Skye Bioscience, Inc. | 18.25M | 10.11% | 335,310 | - |
| 482 | NCEL | NewcelX Ltd. | 17.82M | -0.90% | 4,456 | - |
| 483 | NRSN | NeuroSense Therapeutics Ltd. | 17.67M | -0.62% | 97,565 | - |
| 484 | LPCN | Lipocine Inc. | 17.56M | - | 33,854 | 1.57M |
| 485 | TVRD | Tvardi Therapeutics, Inc. | 17.54M | 1.08% | 103,871 | - |
| 486 | KTTA | Pasithea Therapeutics Corp. | 16.93M | 14.22% | 376,036 | - |
| 487 | OSRH | OSR Health, Inc. | 15.55M | 1.56% | 167,244 | 2.63M |
| 488 | HIND | Vyome Holdings, Inc. | 15.16M | 0.93% | 15,182 | 152.72K |
| 489 | CYCN | Cyclerion Therapeutics, Inc. | 15.14M | 4.21% | 19,552 | 1.90M |
| 490 | MLEC | Moolec Science SA | 14.96M | 5.43% | 1,571 | 7.83M |
| 491 | TPST | Tempest Therapeutics, Inc. | 14.65M | 1.58% | 87,486 | - |
| 492 | PASG | Passage Bio, Inc. | 14.11M | - | 6,365 | - |
| 493 | PTN | Palatin Technologies, Inc. | 14.02M | -1.27% | 18,279 | 12.88M |
| 494 | KALA | KALA BIO, Inc. | 13.90M | 1.49% | 43,132 | - |
| 495 | CMMB | Chemomab Therapeutics Ltd. | 13.90M | 7.22% | 137,590 | - |
| 496 | PBM | Psyence Biomedical Ltd. | 13.24M | -0.57% | 61,812 | - |
| 497 | ICU | SeaStar Medical Holding Corporation | 13.19M | 7.54% | 62,489 | 1.44M |
| 498 | BLRX | BioLineRx Ltd. | 13.11M | -2.87% | 6,691 | 1.40M |
| 499 | AKTX | Akari Therapeutics, Plc | 12.25M | -13.37% | 68,869 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 12.08M | -1.89% | 86,065 | - |